N. Riggi

Discipline

Histoire, Philosophie et Sociologie des sciences (3) Psychologie (2) Economies et finances (1)

Type de document

Articles (31) Recensions (3)

Co-auteur

Date

Source

Mot-clé

Cells (21) Expression (17) protéine (16) Human beings (16) Cancer (16) cancer (14) Cancer (14) Tumors (14) Tumors (14) Sarcoma (13) spectacle (12) Genes (11) Fusion (11) gène (10) Mice (10) Genetic regulation (10) Proteins (9) Gene expression (9) Treatment (8) Observations (8) Observations (8) Chromatin (8) thérapie (7) effet (7) ligne (7) Transcription (7) Therapeutics (7) Melanoma (7) Landscapes (7) Inhibition (7)

Documents écrit par N. Riggi (31) | parle de N. Riggi (0)

Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity.
R. Sanalkumar et al. (31 mars 2023)
EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell Sarcoma.
E. Möller et al. (27 avr. 2022)
Genome-wide functional perturbation of human microsatellite repeats using engineered zinc finger transcription factors.
Y.E. Tak et al. (13 avr. 2022)
Identification of New Vulnerabilities in Conjunctival Melanoma Using Image-Based High Content Drug Screening.
K. Nardou et al. (19 mars 2022)
Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis.
S. Katakam et al.
TWIST1 expression is associated with high-risk neuroblastoma and promotes primary and metastatic tumor growth.
M.V. Sepporta et al. (12 janv. 2022)
A live single-cell reporter assay links intratumor heterogeneity to metastatic proclivity in Ewing sarcoma.
T. Keskin et al.
5-Hydroxymethylcytosine Loss in Conjunctival Melanoma.
A. Stahl et al. (5 juin 2021)
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression.
D. Tavernari et al.
The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependencies.
G. Boulay et al.
Ewing's Sarcoma.
N. Riggi et al. (14 janv. 2021)
Genomic and transcriptomic landscape of conjunctival melanoma.
K. Cisarova et al.
Preclinical Evaluation and Dosimetry of [111In]CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1).
F. Cicone et al.
LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma LIN28B Control of EWS-FLI1 Stability.
T. Keskin et al. (31 mars 2020)
Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways Inhibition.
I. El Zaoui et al. (3 juin 2019)
β-Catenin Expression and Activation in Conjunctival Melanoma.
E. Larivé et al. (2019)
Synovial sarcoma: when epigenetic changes dictate tumour development.
N. Riggi et al. (19 nov. 2018)
Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors.
S. Saghafinia et al. (23 oct. 2018)
Epigenome editing of microsatellite repeats defines tumor-specific enhancer functions and dependencies.
G. Boulay et al. (1 août 2018)
Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis.
G. Fregni et al.
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors.
S. Faes et al. (5 déc. 2016)
IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer.
N. Degrauwe et al. (15 nov. 2016)
Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.
B. Royer-Bertrand et al. (3 nov. 2016)
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors.
S. Faes et al. (14 juin 2016)
The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing.
N. Degrauwe et al. (24 mai 2016)

next